Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Loeb

Showing results (301-310 of 339) with videos related to

Pageof 34
Sort By:
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|October 27, 2020
Zhikang Ye, Bram Rochwerg, Ying Wang, et al.
Infection Control and Hospital Epidemiology|September 11, 2012
Surveillance definitions of infections in long-term care facilities: revisiting the McGeer criteriaNimalie D Stone, Muhammad S Ashraf, Jennifer Calder, et al.
Microbiology Spectrum|January 12, 2024
Risk factors for recognized and unrecognized SARS-CoV-2 infection: a seroepidemiologic analysis of the Prospective Urban Rural Epidemiology (PURE) studyDarryl P Leong, Mark Loeb, Prem K Mony, et al.
Vaccine|May 31, 2017
Burden of vaccine-preventable pneumococcal disease in hospitalized adults: A Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS) network studyJason J LeBlanc, May ElSherif, Lingyun Ye, et al.
Vaccine|March 22, 2022
Recalibrated estimates of non-bacteremic and bacteremic pneumococcal community acquired pneumonia in hospitalized Canadian adults from 2010 to 2017 with addition of an extended spectrum serotype-specific urine antigen detection assayJason J LeBlanc, May ElSherif, Lingyun Ye, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|May 1, 2020
Treatment of patients with nonsevere and severe coronavirus disease 2019: an evidence-based guidelineZhikang Ye, Bram Rochwerg, Ying Wang, et al.
Vaccine|September 11, 2023
Vaccine Effectiveness of non-adjuvanted and adjuvanted trivalent inactivated influenza vaccines in the prevention of influenza-related hospitalization in older adults: A pooled analysis from the Serious Outcomes Surveillance (SOS) Network of the Canadian Immunization Research Network (CIRN)Henrique Pott, Melissa K Andrew, Zachary Shaffelburg, et al.
BMJ Global Health|May 16, 2020
Safe management of bodies of deceased persons with suspected or confirmed COVID-19: a rapid systematic reviewSally Yaacoub, Holger J Schünemann, Joanne Khabsa, et al.
Open Forum Infectious Diseases|February 19, 2025
Oseltamivir Reduces 30-Day Mortality in Older Adults With Influenza: A Pooled Analysis From the 2012-2019 Serious Outcomes Surveillance Network of the Canadian Immunization Research NetworkHenrique Pott, Melissa K Andrew, Zachary Shaffelburg, et al.
The Journal of Infectious Diseases|September 22, 2017
The Importance of Frailty in the Assessment of Influenza Vaccine Effectiveness Against Influenza-Related Hospitalization in Elderly PeopleMelissa K Andrew, Vivek Shinde, Lingyun Ye, et al.
Pageof 34

Showing results (301-310 of 339) with videos related to

Sort By:
Pageof 34
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|October 27, 2020
Zhikang Ye, Bram Rochwerg, Ying Wang, et al.
Infection Control and Hospital Epidemiology|September 11, 2012
Surveillance definitions of infections in long-term care facilities: revisiting the McGeer criteriaNimalie D Stone, Muhammad S Ashraf, Jennifer Calder, et al.
Microbiology Spectrum|January 12, 2024
Risk factors for recognized and unrecognized SARS-CoV-2 infection: a seroepidemiologic analysis of the Prospective Urban Rural Epidemiology (PURE) studyDarryl P Leong, Mark Loeb, Prem K Mony, et al.
Vaccine|May 31, 2017
Burden of vaccine-preventable pneumococcal disease in hospitalized adults: A Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS) network studyJason J LeBlanc, May ElSherif, Lingyun Ye, et al.
Vaccine|March 22, 2022
Recalibrated estimates of non-bacteremic and bacteremic pneumococcal community acquired pneumonia in hospitalized Canadian adults from 2010 to 2017 with addition of an extended spectrum serotype-specific urine antigen detection assayJason J LeBlanc, May ElSherif, Lingyun Ye, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|May 1, 2020
Treatment of patients with nonsevere and severe coronavirus disease 2019: an evidence-based guidelineZhikang Ye, Bram Rochwerg, Ying Wang, et al.
Vaccine|September 11, 2023
Vaccine Effectiveness of non-adjuvanted and adjuvanted trivalent inactivated influenza vaccines in the prevention of influenza-related hospitalization in older adults: A pooled analysis from the Serious Outcomes Surveillance (SOS) Network of the Canadian Immunization Research Network (CIRN)Henrique Pott, Melissa K Andrew, Zachary Shaffelburg, et al.
BMJ Global Health|May 16, 2020
Safe management of bodies of deceased persons with suspected or confirmed COVID-19: a rapid systematic reviewSally Yaacoub, Holger J Schünemann, Joanne Khabsa, et al.
Open Forum Infectious Diseases|February 19, 2025
Oseltamivir Reduces 30-Day Mortality in Older Adults With Influenza: A Pooled Analysis From the 2012-2019 Serious Outcomes Surveillance Network of the Canadian Immunization Research NetworkHenrique Pott, Melissa K Andrew, Zachary Shaffelburg, et al.
The Journal of Infectious Diseases|September 22, 2017
The Importance of Frailty in the Assessment of Influenza Vaccine Effectiveness Against Influenza-Related Hospitalization in Elderly PeopleMelissa K Andrew, Vivek Shinde, Lingyun Ye, et al.
Pageof 34